Roseau, Dominica

Ross University School of Medicine is a private, for-profit Caribbean medical school, owned and operated by DeVry Education Group. The medical school was founded in 1978 and is located on the island nation of Dominica. 98 percent of RUSM students are from the United States and Canada. The 2013 graduating class included 1,100 students.DeVry Education Group, the parent organization that owns RUSM, is a publicly traded company that also owns American University of the Caribbean , another medical school in the Caribbean. Wikipedia.


Time filter

Source Type

News Article | May 4, 2017
Site: www.businesswire.com

DOWNERS GROVE, Ill.--(BUSINESS WIRE)--DeVry Education Group (NYSE:DV), a leading global education provider, today reported academic, operational and financial results for its fiscal 2017 third quarter ended March 31, 2017. DeVry Group also reported enrollment results at its Carrington College, Chamberlain University, DeVry University/Keller Graduate School of Management and DeVry Education of Brazil. “ We remain focused on laying the groundwork to return to consistent revenue growth, while further improving operating efficiencies across our organization,” said Lisa Wardell, president and CEO of DeVry Education Group. “ We are committed to filling the global work force skills gaps that are prevalent in our society through our medical and healthcare, professional education and technology and business program offerings. I’m encouraged with the early traction of our new programs and remain confident that we are taking the right steps to strengthen our value proposition and enhance our growth potential.” Selected financial data for the three months ended March 31, 2017: The fiscal 2017 third quarter results contained pre-tax restructuring charges of $7.8 million primarily related to DeVry University, Carrington College and DeVry Group home office. In the quarter, DeVry Group realigned its reporting segments to reflect its current strategy. For the third quarter, segment revenue of $208.2 million decreased 1.0 percent compared to the prior year, with growth at Chamberlain University more than offset by decreased revenue at the medical and veterinary schools. Chamberlain revenue increased 2.4 percent to $124.9 million, while revenue for the medical and veterinary schools decreased 5.7 percent to $83.2 million. Third quarter operating income for the segment, excluding special items, was $50.8 million, representing a decrease of 11.5 percent from the prior year. Building on the strength of its brand and reputation, Chamberlain has broadened its reach in healthcare education through the establishment of Chamberlain University and the launch of a Master of Public Health (MPH) degree program within its new College of Health Professions. The Master of Public Health degree program enhances Chamberlain’s continued focus on providing health and wellness education, improving healthcare policy through interdisciplinary collaboration and making health a shared value across communities. During the fiscal third quarter, Ross University School of Veterinary Medicine (Ross) was awarded a grant by the National Institutes of Health (NIH) to study mosquito-transmitted arboviruses such as chikungunya, dengue and Zika, which have emerged as global public health threats. Ross will study these viruses in an effort to advance the understanding of how they may be transmitted between animals and humans. Led by Ross, the research is a collaborative effort with investigators at Kansas State University and the University of Georgia. It is the first NIH grant awarded to a research team at Ross. Third quarter segment revenue increased 25.9 percent to $29.8 million compared to the prior year, driven by the Association of Certified Anti-Money Laundering Specialists (ACAMS) acquisition. Segment operating income for the third quarter was $2.6 million, down from $5.9 million from the prior year, driven by a decline in revenue in Becker’s CPA review program and ACAMS revenue seasonality. Becker has continued to focus on growing global revenue through its continuing education programs and through ACAMS. Third quarter segment revenue increased 28.6 percent to $61.8 million compared to the prior year. On a constant currency basis, revenue in the segment grew 5.3 percent driven in part by recent acquisitions. Segment operating income in the third quarter was $5.4 million, up from a loss of $1.6 million in the prior year. DeVry Education of Brazil (DVE) introduced several programs during the quarter such as a new architectural program at Ibmec and a Master’s of Education degree program at Damásio. DVE is focused on leveraging its curriculum and its brands to attract new students. DeVry Education of Brazil launched a new Ibmec campus in São Paulo during the third quarter, which is intended to expand the institution’s access to a broader student population in the primary economic center of the country. In the third quarter, segment revenue decreased 20.8 percent to $153.0 million. Revenue at DeVry University decreased 23.7 percent to $119.4 million during the third quarter, compared to the prior year. Third quarter revenue at Carrington declined 8.3 percent to $33.5 million compared to the prior year. The segment recorded breakeven operating income for the quarter, compared to $1.7 million in the prior year, excluding special items. DeVry University achieved $32.9 million of cost savings in the third quarter compared to prior year, excluding special items. Additional cost reductions are expected in the fourth quarter of fiscal 2017 to maintain positive segment economics. Fourth quarter revenue is expected to be down 3 to 4 percent versus the prior year. Fourth quarter operating costs before special items are expected to decrease 4 to 5 percent versus the prior year. For the full year, revenue is expected to be down 1 to 2 percent compared to the prior year and earnings before special items are expected to grow in the mid-teens range as compared to the prior year. Full year capital spending is expected to be in the $55-60 million range. The effective income tax rate for the fiscal year is expected to be in the range of 20 to 21 percent, before special items. DeVry Group will hold a conference call to discuss its fiscal 2017 third quarter financial results on May 4, 2017 at 4 p.m. Central (5 p.m. Eastern). The conference call will be led by Lisa Wardell, president and CEO, and Patrick Unzicker, CFO and treasurer. For those wishing to participate by telephone, dial 877-407-6184 (domestic) or 201-389-0877 (international). Ask for the “DeVry Education Group Call” or use conference ID: 13655813. DeVry Group will also broadcast the conference call on DeVry Group's website at: http://www.investorcalendar.com/IC/CEPage.asp?ID=175878. Please access the website at least 15 minutes prior to the start of the call to register, download and install any necessary audio software. DeVry Group will archive a telephone replay of the call until Friday, May 19, 2017. To access the replay, dial 877-660-6853 (domestic) or 201-612-7415 (international). To access the webcast replay, please visit DeVry Group's website, or: http://www.investorcalendar.com/IC/CEPage.asp?ID=175878. Since 1931 DeVry Education Group has empowered its students to achieve their educational and career goals. DeVry Education Group Inc. (NYSE: DV; member S&P MidCap 400 Index) is a leading global education provider and the parent organization of American University of the Caribbean School of Medicine, Becker Professional Education, Carrington College, Chamberlain University, DeVry Education of Brazil, DeVry University and its Keller Graduate School of Management, Ross University School of Medicine and Ross University School of Veterinary Medicine. For more information, please visit www.devryeducationgroup.com. Certain statements contained in this release concerning DeVry Group's future performance, including those statements concerning DeVry Group's expectations or plans, may constitute forward-looking statements subject to the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as DeVry Group or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Actual results may differ materially from those projected or implied by these forward-looking statements. Potential risks, uncertainties and other factors that could cause results to differ are described more fully in Item 1A, "Risk Factors," in DeVry Group's most recent Annual Report on Form 10-K for the year ending June 30, 2016 and filed with the Securities and Exchange Commission (SEC) on August 25, 2016 and its most recent Quarterly Report on Form 10-Q for the quarter ending December 31, 2016 and filed with the SEC on February 2, 2017. During the third quarter and first nine months of fiscal year 2017, DeVry Group recorded special items related to the following: (i) Restructuring charges related to severance for workforce reductions and real estate consolidations at the medical and veterinary schools which is part of the Medical and Healthcare segment, DeVry University and Carrington College ("Carrington") which are part of the U.S. Traditional Postsecondary segment, and DeVry Group's home office (not related to any segment) in order to align its cost structure with enrollments; (ii) Charges related to regulatory settlement agreements; and (iii) A charge related to an asset fair value write-down of its Pomona, California campus. During the third quarter and first nine months of fiscal year 2016, DeVry Group recorded special items related to the following: (i) Restructuring charges related to workforce reductions and real estate consolidations at DeVry University and real estate consolidations at Carrington in order to align its cost structure with enrollments; (ii) An asset impairment charge related to the write-down of Carrington's intangible assets and goodwill; (iii) A charge related to an asset fair value write-down at Becker Professional Education which is part of the Professional Education segment; and (iv) A gain on the sale of the DeVry University, Fremont, California campus and student housing facilities. The following tables illustrate the effects of the special items on DeVry Group’s operating income and net income. Management believes that the non-GAAP disclosure of operating income and net income excluding these special items provides investors with useful supplemental information regarding the underlying business trends and performance of DeVry Group’s ongoing operations and is useful for period-over-period comparisons of such operations given the special nature of the restructuring charges, regulatory settlements, loss on assets held for sale, an asset impairment charge and gain on sale of assets. DeVry Group uses these supplemental financial measures internally in its management and budgeting process. However, these non-GAAP financial measures should be viewed in addition to, and not as a substitute for, DeVry Group’s reported results prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"). The following tables reconcile these non-GAAP measures to the most directly comparable GAAP information (in thousands):


News Article | December 15, 2016
Site: www.businesswire.com

DOWNERS GROVE, Ill.--(BUSINESS WIRE)--DeVry Education Group and DeVry University have agreed to settle litigation brought by the Federal Trade Commission regarding DeVry University’s use of employment statistics in former advertising. We have agreed to pay $49.4 million to be distributed at the sole discretion of the FTC; forgive $30.4 million of institutional loans issued before Sept. 30, 2015; and forgive outstanding DeVry University accounts receivable balances by $20.2 million for former students. DeVry Group expects to record a related pre-tax settlement charge in the range of $52 million to $55 million in the second quarter of fiscal year 2017 arising from the monetary terms of the settlement. In addition, DeVry Group agreed that its institutions marketing to U.S. consumers will maintain specific substantiation to support any future advertising regarding graduate outcomes and educational benefits, and will implement training and other agreed-upon compliance measures. We anticipate the settlement will be entered as an agreed order by the court. DeVry Group chose to settle this action after filing an answer denying all allegations of wrongdoing. Student services and access to federal student loans are not impacted by the settlement, and at no time has the academic quality of a DeVry University education been questioned. DeVry Group is pleased this matter is reaching resolution, particularly as its institutions implement recently announced Student Commitments and as we continue our focus on investments that directly support our students’ success. Since 1931 DeVry Education Group has empowered its students to achieve their educational and career goals. DeVry Education Group Inc. (NYSE: DV; member S&P MidCap 400 Index) is a leading global education provider and the parent organization of American University of the Caribbean School of Medicine, Becker Professional Education, Carrington College, Chamberlain College of Nursing, DeVry Education of Brazil, DeVry University and its Keller Graduate School of Management, Ross University School of Medicine and Ross University School of Veterinary Medicine. For more information, please visit www.devryeducationgroup.com. Certain statements contained in this press release, including those that affect the expectations or plans of DeVry University or DeVry Group, may constitute forward-looking statements subject to the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as DeVry University, DeVry Group or their management “anticipates,” “believes,” “estimates,” “expects,” “forecasts,” “foresees,” “intends,” “plans” or other words or phrases of similar import. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause DeVry Group’s actual results to differ materially from those projected or implied by these forward-looking statements. Potential risks, uncertainties and other factors that could cause results to differ are described more fully in Item 1A, "Risk Factors," in DeVry Group’s Annual Report on Form 10-K for the fiscal year ended June 30, 2016 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2016. These forward-looking statements are based on information as of December 15, 2016, and DeVry Group assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized.


News Article | November 29, 2016
Site: www.24-7pressrelease.com

GIBSONIA, PA, November 29, 2016-- Anil C. Singh, Physician and Assistant Professor of Medicine at Allegheny Health Network, has been recognized for showing dedication, leadership and excellence in internal medicine.Worldwide Branding, the world's leading international personal branding organization, is proud to endorse the notable professional efforts and accomplishments of Anil C. Singh. A member in good standing, Dr. Singh parlays 16 years' experience into his professional network, and has been noted for achievements, leadership abilities, and the credentials he has provided in association with his Worldwide Branding membership.Dr. Singh is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema, and other complex disorders of the lungs. He is a practicing pulmonary disease specialist in Pittsburgh. Dr. Singh also specializes in critical care medicine and internal medicine. He accepts multiple insurance plans, including Aetna, QualCare and UPMC. He is board certified in internal medicine, critical care medicine, and pulmonary disease.Dr. Singh holds special expertise in eight areas: asthma, chronic obstructive pulmonary disease (COPD); cystic fibrosis, emphysema, lung cancer, pulmonary hypertension sleep apnea and sleep disorders. He has contributed to 10 publications, as well. He is board certified in internal medicine with additional board certifications in pulmonary medicine, critical care medicine and neurocritical care medicine. He earned an MD from Ross University School of Medicine in 2001 and a Master of Clinical Gerontology from Baylor University. He also holds a Master of Public Health, earned from the UT Health Science Center, and a Bachelor of Science from Baylor University in 1994. In order to maintain ties to other industry professionals, Dr. Singh became a member of the ACCP, the American Thoracic Society, the NCS and the Society of Critical Care Medicine.Dr. Singh has been named as one of America's Best Doctors in Critical Care by Pittsburgh Magazine in 2011, and he received a Clinical Teaching Recognition Award through the Multidisciplinary Critical Care Training Program at UPMC. He took first place for his oral presentation on "Survival After 42 Hours of Carbon Monoxide Exposure from a Mining Accident with Hyperbaric Oxygen Therapy," conducted before the American College of Chest Physicians in 2006.Worldwide Branding has added Dr. Singh to their distinguished Registry of Executives, Professionals and Entrepreneurs. While inclusion in Worldwide Branding is an honor, only small selections of members in each discipline are endorsed and promoted as leaders in their professional fields.About Worldwide BrandingFor more than 15 years, Worldwide Branding has been the leading, one-stop-shop, personal branding company, in the United States and abroad. From writing professional biographies and press releases, to creating and driving Internet traffic to personal websites, our team of branding experts tailor each product specifically for our clients' needs. From health care to finance to education and law, our constituents represent every major industry and occupation, at all career levels.For more information, please visit http://www.worldwidebranding.com


News Article | February 16, 2017
Site: www.businesswire.com

DOWNERS GROVE, Ill.--(BUSINESS WIRE)--DeVry Education Group (NYSE:DV), a leading global education provider, today announced that its board of directors has approved its tenth share repurchase program, which allows DeVry Group to repurchase up to $300 million of its common stock through December 31, 2020. In conjunction with the new program, which replaces DeVry Group’s previously approved $100 million share repurchase authorization, the company will cease its bi-annual cash dividend payment. “The significant expansion of our share repurchase program reflects our improved financial performance and our board’s confidence in our strategic direction as well as our focus on delivering increased returns to our owners,” said Lisa Wardell, president and CEO of DeVry Education Group. “We remain committed to balancing our capital allocation efforts with the goal of enhancing academic quality, supporting our growth objectives and consistently delivering value to our shareholders.” The timing and amount of any repurchase will be determined by management and the board based on evaluation of market conditions and other factors. These repurchases may be made through the open market, including block purchases, in privately negotiated transactions, or otherwise. The repurchases will be funded through available cash balances and/or borrowings, and may be suspended or discontinued at any time. Since 1931 DeVry Education Group has empowered its students to achieve their educational and career goals. DeVry Education Group Inc. (NYSE: DV; member S&P MidCap 400 Index) is a leading global education provider and the parent organization of American University of the Caribbean School of Medicine, Becker Professional Education, Carrington College, Chamberlain College of Nursing, DeVry Education of Brazil, DeVry University and its Keller Graduate School of Management, Ross University School of Medicine and Ross University School of Veterinary Medicine. For more information, please visit www.devryeducationgroup.com. Certain statements contained in this release concerning DeVry Group's future performance, including those statements concerning DeVry Group's expectations or plans, may constitute forward-looking statements subject to the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as DeVry Group or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Actual results may differ materially from those projected or implied by these forward-looking statements. Potential risks, uncertainties and other factors that could cause results to differ are described more fully in Item 1A, "Risk Factors," in DeVry Group's most recent Annual Report on Form 10-K for the year ending June 30, 2016 and filed with the Securities and Exchange Commission (SEC) on August 25, 2016 and its most recent Quarterly Report on Form 10-Q for the quarter ending December 31, 2016 and filed with the SEC on February 2, 2017.


Butler T.,Ross University School of Medicine
Transactions of the Royal Society of Tropical Medicine and Hygiene | Year: 2012

Haemolytic uraemic syndrome (HUS), which is comprised of the triad of haemolytic anemia, thrombocytopenia and renal insufficiency, occurs in about 13% of dysenteric patients with shigellosis due to . Shigella dysenteriae type 1 (SD1) infections, who are mostly children less than five years old in Africa and Asia. With a case-fatality rate of about 36%, it is the leading cause of death in SD1 outbreaks. Research suggests that Shiga toxin and lipopolysaccharide from the causative bacteria play roles in pathogenesis. The risk of HUS is increased when inappropriate antimicrobial drugs, against which infecting bacteria are resistant, are used or when any antimicrobial drug is given more than four days after the start of diarrhoea. To prevent HUS, it is advised to initiate an appropriate drug early and to consider withholding antimicrobial therapy in patients presenting more than four days after the onset of diarrhoea. © 2012 Royal Society of Tropical Medicine and Hygiene.


Butler T.,Ross University School of Medicine
Clinical Microbiology and Infection | Year: 2011

Emergence of multidrug resistance and decreased ciprofloxacin susceptibility (DCS) in Salmonella enterica serovar Typhi in South Asia have rendered older drugs, including ampicillin, chloramphenicol, trimethoprim-sulphamethoxazole, ciprofloxacin, and ofloxacin, ineffective or suboptimal for typhoid fever. Ideally, treatment should be safe and available for adults and children in shortened courses of 5 days, cause defervescence within 1 week, render blood and stool cultures sterile, and prevent relapse. In this review of 20 prospective clinical trials that enrolled more than 1600 culture-proven patients, azithromycin meets these criteria better than other drugs. Among fluoroquinolones, which are more effective than cephalosporins, gatifloxacin appears to be more effective than ciprofloxacin and ofloxacin for patients infected with bacteria showing DCS. Ceftriaxone continues to be useful as a back-up choice, and chloramphenicol, despite its toxicity for bone marrow and history of plasmid-mediated resistance, is making a comeback in developing countries that show their bacteria to be susceptible to it. © 2011 The Author. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.


Moffett J.,Ross University School of Medicine
Medical Teacher | Year: 2015

The flipped classroom is a pedagogical model in which the typical lecture and homework elements of a course are reversed. The following tips outline the steps involved in making a successful transition to a flipped classroom approach. The tips are based on the available literature alongside the author's experience of using the approach in a medical education setting. Flipping a classroom has a number of potential benefits, for example increased educator-student interaction, but must be planned and implemented carefully to support effective learning. © 2014 Informa UK Ltd. All rights reserved.

Loading Ross University School of Medicine collaborators
Loading Ross University School of Medicine collaborators